Activation of 4E-BP1 reduces the levels of the oncogenic proteins ribonucleotide reductase M2 (RRM2) and polo-like kinase 1 (PLK1) in Ewing and other sarcoma cell lines. The gene discussed is PLK1; the disease is sarcoma.